← Evidence map

ArticlemAbs

Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site.

Karl J M Hanf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2020
2021
2022
2023
2024
2025
2026
cites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31928294